Last update 09 Aug 2025

SMP-3124

Overview

Basic Info

Drug Type
Small molecule drug, Liposomal Drug
Synonyms
SMP 3124, SMP3124
Target
Chk1
Action
inhibitors
Mechanism
Chk1 inhibitors(Checkpoint kinase 1 inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication
Advanced Malignant Solid NeoplasmSolid tumorOvarian Cancer
Inactive Indication-
Originator Organization
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
Active Organization
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SMP-3124
NCT06526819
/ RecruitingPhase 1/2
An Open-label, Phase 1 Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of SMP-3124LP in Adults With Advanced Solid Tumors
100 Clinical Results associated with SMP-3124
Login to view more data
100 Translational Medicine associated with SMP-3124
Login to view more data
100 Patents (Medical) associated with SMP-3124
Login to view more data
100 Deals associated with SMP-3124
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
United States
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.
14 Aug 2024
Advanced Malignant Solid NeoplasmPhase 2
Japan
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.
14 Aug 2024
Solid tumorPhase 2
United States
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
-
Ovarian CancerPreclinical
United States
Sumitomo Pharma America, Inc.Sumitomo Pharma America, Inc.
28 Apr 2025
Ovarian CancerPreclinical
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
28 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free